IgP antibodies (MultiCell)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIgP antibodies (MultiCell)
Drug Alias Nameimmunoglobulin peptide antibodies (MultiCell)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT lymphocytes inhibitorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusMultiple SclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMulticell Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMulticell Technologies
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusMultiple SclerosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A